is subject to confounding by hospital (treatment highly dependent on the hospital, different SOC/ICU transfer practices, not included in PS), immortal time (only partly addressed in sensitivity analysis), co-treatment differences, calendar-time (SOC evolved rapidly early in the pandemic), binary coding for age (age 65 despite steep age-risk gradient), residual imbalance (variables dropped from PS), a composite outcome dependent on hospital triage/capacity, and other factors
Koushki M, Amiri-Dashatan N, Ahmadi N, Abbaszadeh H, Rezaei-Tavirani M
Disclaimer: KLOW is only sold for the purpose of research and is not to be viewed as a medicinal product
doi: 10.1038/s41467-021-24859-2 17 AlborziniaHFlrezAFKrethSBrcknerLMYildizUGartlgruberMet al
100mg x box of 10 for $39